This is the authors' abstract. We don't add key points for this paper.
Electrochemical reduction of CO2 is a promising approach to convert CO2 to high-valued chemicals and fuels. However, developing efficient electrocatalysts featuring desirable activity and selectivity is still a big challenge. In this work, a strategy of introducing functionalized molecules with desirable CO2 affinity to regulate Ag catalyst for promoting electrochemical reduction of CO2 was proposed. Specifically, 3-mercapto-1,2,4-triazole was introduced onto the Ag nanoparticle (Ag-m-Triz) for the first time to achieve selectively converting CO2 to carbon monoxide (CO). This Ag-m-Triz exhibits excellent performance for CO2 reduction with a high CO Faradaic efficiency (FECO) of 99.2% and CO partial current density of 85.0 mA/cm2 at -2.3 V vs. Ag/Ag+ in H-cell when combined with the ionic liquid-based electrolyte, 30 wt% 1-butyl-3-methylimidazolium hexafluorophosphate ([Bmim][PF6])-65 wt% acetonitrile (AcN)-5 wt% H2O, which is 2.5-fold higher than the current density in Ag-powder under the same condition. Mechanism studies confirm that the significantly improved performance of Ag-m-Triz originates from (i) the stronger adsorption ability of CO2 molecule and (ii) the weaker binding energy to form the COOH* intermediate on the surface of Ag-m-Triz compared with the Ag-powder catalyst, which boosts the conversion of CO2 to CO. This research provides a facile way to regulate electrocatalysts for efficient CO2 reduction by introducing functionalized molecules.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: